Trial Profile
An Open Label Assessment of the Effect of Coadministration of Posaconazole or Pantoprazole on Systemic Exposure of F901318 and the Effect of F901318 on the Single Dose Pharmacokinetics of Tacrolimus and Cyclosporine A in Healthy Male and Female Subjects
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase I
Latest Information Update: 15 Mar 2021
Price :
$35
*
At a glance
- Drugs Olorofim (Primary) ; Ciclosporin; Pantoprazole; Posaconazole; Tacrolimus
- Indications Coccidioidomycosis; Invasive bronchopulmonary aspergillosis; Mycoses
- Focus Pharmacokinetics
- Sponsors F2G
- 30 Oct 2017 Status changed from not yet recruiting to withdrawn prior to enrolment.
- 31 Mar 2017 New trial record